| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 352.85M | 452.70M | 238.72M | 180.36M | 121.62M | 100.27M |
| Gross Profit | 116.06M | 182.90M | 56.92M | 4.98M | 9.94M | 14.59M |
| EBITDA | -269.00M | 51.46M | -22.31M | -68.41M | -27.43M | -11.37M |
| Net Income | -305.28M | 13.38M | -45.81M | -82.74M | -37.09M | -21.81M |
Balance Sheet | ||||||
| Total Assets | 491.39M | 895.14M | 703.05M | 643.42M | 182.95M | 97.42M |
| Cash, Cash Equivalents and Short-Term Investments | 150.72M | 220.88M | 139.72M | 281.33M | 76.56M | 16.50M |
| Total Debt | 150.16M | 197.38M | 138.77M | 119.40M | 15.24M | 8.31M |
| Total Liabilities | 185.66M | 280.44M | 214.99M | 195.98M | 54.55M | 29.57M |
| Stockholders Equity | 305.73M | 614.71M | 488.06M | 447.44M | 128.41M | 67.85M |
Cash Flow | ||||||
| Free Cash Flow | 2.69M | -40.71M | -218.07M | -272.37M | -32.41M | -13.34M |
| Operating Cash Flow | 52.42M | 45.55M | -42.61M | -94.40M | -18.63M | -9.92M |
| Investing Cash Flow | -49.74M | -86.26M | -175.46M | -177.97M | -13.78M | -3.42M |
| Financing Cash Flow | 35.86M | 122.02M | 75.48M | 478.37M | 92.47M | 26.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $260.95M | 18.89 | 17.68% | ― | 30.74% | -13.58% | |
66 Neutral | $493.69M | 36.69 | 2.20% | ― | -0.19% | -50.51% | |
64 Neutral | $834.41M | 19.00 | 8.83% | 2.68% | 1.19% | -56.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $1.48B | 674.86 | 13.29% | ― | -9.21% | -97.43% | |
54 Neutral | $705.22M | ― | -28.88% | 2.07% | 43.81% | -584.11% | |
44 Neutral | $244.64M | -0.80 | -75.06% | ― | -14.74% | -20086.56% |
On December 16, 2025, Aspen Aerogels and its affiliates amended their existing MidCap credit facility, raising the minimum liquidity threshold tied to the term loan balance, eliminating the minimum EBITDA covenant, revising mandatory prepayment terms to apply asset-sale proceeds to reduce amortization in order of maturity, and lowering the basket for permitted acquisitions. In a December 17, 2025 announcement, the company said the changes strengthen its financial position and provide added covenant flexibility, reflecting a liquidity outlook that is running ahead of expectations due to operational efficiencies, working-capital improvements and disciplined capital spending, which together should support execution of its growth strategy into 2026 and may reassure lenders and investors about its balance-sheet resiliency.
Aspen Aerogels reported a decrease in total revenue to $73.0 million for Q3 2025, down from $117.3 million in Q3 2024, alongside a reduced net loss of $6.3 million compared to $13.0 million the previous year. The company updated its 2025 outlook to reflect lower demand in the U.S. EV market, while highlighting growth opportunities in its Energy Industrial segment for 2026 and a significant PyroThin® contract with a European OEM. Aspen is focusing on cost reduction and operational efficiency to stabilize and grow its business amid market challenges.